|
⚲
|
| Keyboard |
| Douglas Morton | |
|---|---|
| Firm | |
| Address | 38 Fulton St W Suite 303 Grand Rapids, MI 49503 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Tetra Discovery Partners Inc | 021-329501 | Director | 35.8 M of 35.8 M |
||
| Tetra Discovery Partners Inc | 021-290686 | Director | 0.5 M of 1.5 M |
||
| Tetra Discovery Partners Inc | 021-268185 | Director | 4.3 M of 7.3 M |
||
| Tolera Therapeutics Inc | 021-224862 | Director | 0.2 M | ||
| Tolera Therapeutics Inc | 021-204179 | Director | 1.1 M | ||
| Tolera Therapeutics Inc | 021-185110 | Director | 5.4 M of 5.4 M |
||
| Tolera Therapeutics Inc | 021-183059 | Director | 0.8 M of 0.8 M |
||
| Tolera Therapeutics Inc | 021-178252 | Director | 1.5 M of 2.0 M |
||
| Tolera Therapeutics Inc | 021-170434 | Director | 0.9 M of 1.6 M |
||
| Tolera Therapeutics Inc | 021-142893 | Director | 4.1 M of 6.1 M |
||
| Nephrx Corp | 021-55551 | Director | 6.2 M of 6.2 M |
||